Dow Down0.02% Nasdaq Up0.07%

MannKind Corp. (MNKD)

-NasdaqGM
6.20 0.04(0.65%) Nov 25, 4:00PM EST
ProfileGet Profile for:
MannKind Corp.
28903 North Avenue Paine
Valencia, CA 91355
United States - Map
Phone: 661-775-5300
Website: http://www.mannkindcorp.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:265

Business Summary 

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate is AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company is also developing MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on MannKind Corp.

Corporate Governance 
MannKind Corp.’s ISS Governance QuickScore as of Nov 1, 2014 is 10. The pillar scores are Audit: 5; Board: 6; Shareholder Rights: 3; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Alfred E. Mann , 88
Founder, Chairman and Chief Exec. Officer
1.32M0.00
Mr. Hakan S. Edstrom B.Sc., M.B.A., 64
Pres, Chief Operating Officer and Director
1.18M0.00
Mr. Matthew J. Pfeffer CPA, 56
Chief Financial Officer, Principal Accounting Officer and Corp. VP
700.00K51.00K
Dr. Juergen A. Martens Ph.D., 58
Chief Technical Officer and Corp. VP of Technical Operations
740.00K62.00K
Dr. David B. Thomson Ph.D., J.D., 47
Corp. VP, Gen. Counsel and Corp. Sec.
615.00K496.00K
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders